We are live on ! Find out more
GA

General Atlantic Portfolio holdings

AUM $2.15B
1-Year Est. Return 35.02%
This Fund
S&P 500
This Quarter Est. Return
+21.49%
1 Year Est. Return
+35.02%
3 Year Est. Return
+185.68%
5 Year Est. Return
+122.28%
10 Year Est. Return
+1,080.07%
AUM
$2.98B
AUM Growth
+$170M
Cap. Flow
-$34.7M
Cap. Flow %
-1.16%
Top 10 Hldgs %
98.5%
Holding
16
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
THRD
Third Harmonic Bio
THRD
+$34.7M

Sector Composition

Rank Sector Weight
1 Healthcare 57.12%
2 Technology 27.22%
3 Financials 13.67%
4 Consumer Staples 1.85%
5 Consumer Discretionary 0.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALHC icon
1
Alignment Healthcare
ALHC
$3.73B
$1.14B 38.12%
60,993,323
– –
DLO icon
2
dLocal
DLO
$4.34B
$533M 17.89%
63,906,695
– –
XP icon
3
XP
XP
$8.5B
$407M 13.67%
29,617,733
– –
ALKT icon
4
Alkami Technology
ALKT
$1.96B
$253M 8.5%
9,645,318
– –
AKRO
5
DELISTED
Akero Therapeutics
AKRO
$212M 7.11%
5,233,989
– –
CNTA
6
DELISTED
Centessa Pharmaceuticals
CNTA
$139M 4.67%
9,681,818
– –
PHVS icon
7
Pharvaris
PHVS
$2.34B
$118M 3.97%
7,531,252
– –
EWCZ
8
DELISTED
European Wax Center
EWCZ
$51.8M 1.74%
13,110,492
– –
RPRX icon
9
Royalty Pharma
RPRX
$26.6B
$46.7M 1.57%
1,500,000
– –
IMCR icon
10
Immunocore
IMCR
$1.7B
$37.4M 1.26%
1,261,684
– –
RSKD icon
11
Riskified
RSKD
$731M
$24.6M 0.83%
5,324,998
– –
SLRN
12
DELISTED
ACELYRIN
SLRN
$6.66M 0.22%
2,695,327
– –
ADAG
13
Adagene
ADAG
$245M
$5.82M 0.2%
3,825,952
– –
LOGC
14
DELISTED
ContextLogic
LOGC
$4.26M 0.14%
609,616
– –
GROV icon
15
Grove Collaborative
GROV
$45.8M
$3.34M 0.11%
2,474,859
– –
THRD
16
DELISTED
Third Harmonic Bio
THRD
– –
-3,372,323
Closed -$34.7M

Similar funds

NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return
AAP
Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return
RFP
Root Financial Partners Encinitas, California $2.16B AUM 18.08% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

General Atlantic's Q1 2025 Portfolio in Review

As of Q1 2025, General Atlantic held 16 positions worth $2.98B, up 6% from $2.81B the previous quarter. Its ten largest holdings account for 99% of the portfolio.

General Atlantic's Q1 2025 filing shows 1 closed position. The largest sale was Third Harmonic Bio, an estimated $34.7M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 45% a quarter earlier, followed by Technology and Financials.

  • General Atlantic fully exited Third Harmonic Bio in Q1 2025, selling an estimated $34.7M.
  • General Atlantic's ten largest holdings make up 99% of its $2.98B portfolio in Q1 2025.
  • General Atlantic opened 0 new positions and closed 1 in Q1 2025.
  • General Atlantic's portfolio value rose 6% quarter-over-quarter to $2.98B.

Based on General Atlantic's 13F filing for Q1 2025, filed 14 May 2025.